Connect Sign In
March is National Colorectal Cancer Awareness Month. ARUP Consult® provides clinicians with clear guidance on screening options and testing recommendations for colorectal cancer. |
March 5, 2026 |
Colorectal Cancer Screening: Earlier Testing, Expanded Options Now Reflected in ARUP Consult… The ARUP Consult Colorectal Cancer topic highlights updated screening recommendations |
Visit us at booth #2106 to learn more about emerging research and the latest updates in genetic testing. |
March 3, 2026 |
ARUP Medical Directors and Genetic Specialists To Showcase Latest Research at ACMG… ARUP research highlights include cytogenetic abnormalities of pediatric B-cell acute |
Kamisha Johnson-Davis, PhD, MBA, DABCC (CC, TC), ARUP medical director of Clinical Toxicology, contributed her expertise to the development of new guidance for emergency department drug testing. |
January 27, 2026 |
ARUP Medical Director Contributes to New ADLM Emergency Department Guidance… New ADLM guidance helps emergency department providers choose and interpret urine drug |
Visit ARUP at booth #1180 to connect with our experts, learn about the latest in testing for blood disorders, and test your diagnostic skills. |
December 2, 2025 |
ARUP Experts Will Showcase Their Latest Research at the ASH Annual Meeting and Exposition ARUP experts will showcase their latest research at the ASH Annual Meeting and Exposition, including |
Kelly Doyle, PhD, DABCC, FADLM, and fellow colleagues have validated age-specific reference intervals to better identify pediatric patients who have glucose-6-phosphate dehydrogenase (G6PD) deficiency. Join Doyle for a webinar, “Development of Pediatric G6PD Reference Intervals Through Integration of Indirect Methods and Molecular Data,” on December 17, 2025, at 11 a.m. |
November 12, 2025 |
ARUP Uses Statistical Modeling To Establish Reference Intervals for Pediatric… ARUP has used novel statistical modeling approaches to establish age-specific reference ranges |
|
November 7, 2025 |
New Resource Discusses DPYD Genotyping Test Selection, Interpretation The FDA and the National Comprehensive Cancer Network (NCCN) urge DPYD testing before chemotherapy. ARUP |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ We accelerate the development and adoption of cutting-edge diagnostic and prognostic technologies advancing patient care through groundbreaking science and engineering. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
Test Information
